SCHEMBL6002064

SCHEMBL6002064

O=c1oc2c(-c3ccc(F)cc3)cc(O)cc2s1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.73
MEN1 O00255 2/20 0.73
KMT2A Q03164 2/20 0.73
ALDH1A1 P00352 3/20 0.67
POLB P06746 2/20 0.67
CTDSP1 Q9GZU7 1/20 0.67
HPGD P15428 3/20 0.43
KDM4E B2RXH2 2/20 0.43
GAA P10253 2/20 0.43
RAB9A P51151 2/20 0.43
GLA P06280 1/20 0.43
MIF P14174 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CA2 P00918 1/20 0.41
ALPI P09923 1/20 0.41
ALPG P10696 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001366 0.85 MAPT (0.68) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL5307613 0.85 MAPT (0.68) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL31196638 0.85 MAPT (0.68) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL6000106 0.85 MAPT (0.77) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL15503719 0.85 MAPT (1.00) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL6002075 0.82 MAPT (0.67) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL6000117 0.80 MAPT (0.69) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL6001497 0.76 MAPT (0.72) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL6001485 0.76 MAPT (0.72) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL6001607 0.76 MAPT (0.72) MAPTMEN1KMT2AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060234987-A1 Neuroprotective benzo 1 3 oxathiol 2 ones JAQUITH JAMES B 2006-10-19 US claimed
WO-2005012281-A1 NEUROPROTECTIVE BENZO[1,3]OXATHOL-2-ONES AEGERA THERAPEUTICS INC. (CA) 2005-02-10 WO claimed
US-20060234987-A1 Neuroprotective benzo 1 3 oxathiol 2 ones JAQUITH JAMES B 2006-10-19 US disclosed
WO-2005012281-A1 NEUROPROTECTIVE BENZO[1,3]OXATHOL-2-ONES AEGERA THERAPEUTICS INC. (CA) 2005-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060234987-A1 Neuroprotective benzo 1 3 oxathiol 2 ones NLN, SMN1; SMN2, TXN2 MAPT 204/4885MEN1 4526/4885KMT2A 4306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.